Biosynex SA
PAR:ALBIO

Watchlist Manager
Biosynex SA Logo
Biosynex SA
PAR:ALBIO
Watchlist
Price: 2.9 EUR -3.17% Market Closed
Market Cap: 31.2m EUR
Have any thoughts about
Biosynex SA?
Write Note

Wall Street
Price Targets

ALBIO Price Targets Summary
Biosynex SA

Wall Street analysts forecast ALBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALBIO is 12.85 EUR with a low forecast of 12.73 EUR and a high forecast of 13.23 EUR.

Lowest
Price Target
12.73 EUR
339% Upside
Average
Price Target
12.85 EUR
343% Upside
Highest
Price Target
13.23 EUR
356% Upside
Biosynex SA Competitors:
Price Targets
7575
Japan Lifeline Co Ltd
9% Upside
PRN
Profound Medical Corp
44% Upside
7733
Olympus Corp
17% Upside
688212
Shanghai Aohua Photoelectricity Endoscope Co Ltd
22% Upside
SRDX
Surmodics Inc
16% Upside
688626
Xiangyu Medical Co Ltd
118% Upside
RMD
Resmed Inc
1% Downside
SUS
Surgical Science Sweden AB
46% Upside

Revenue
Forecast

Revenue Estimate
Biosynex SA

For the last 8 years the compound annual growth rate for Biosynex SA's revenue is 32%. The projected CAGR for the next 2 years is 26%.

32%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biosynex SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Biosynex SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALBIO's stock price target?
Price Target
12.85 EUR

According to Wall Street analysts, the average 1-year price target for ALBIO is 12.85 EUR with a low forecast of 12.73 EUR and a high forecast of 13.23 EUR.

What is Biosynex SA's Revenue forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for Biosynex SA's revenue is 32%. The projected CAGR for the next 2 years is 26%.

Back to Top